Event Type
Disclosure
Mandatory
Variant
8-K
of this Form 8-K is hereby incorporated by reference herein. Forward-Looking Statements The disclosure in this Current Report on Form 8-K contains “forward-look
of this Current Report on Form 8-K (including Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3) shall not be deemed “filed” for purposes of Section 18 of the Securi
Other Matters. Data Releases The Company is a clinical-stage C lustered R egularly I nterspaced S hort P alindromic R epeats (“CRISPR”) genome-editing biopharma
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release Issued by Caribou Biosciences, Inc. on November 3 , 2025 99.2 Press R